ABVC BioPharma, Inc. (ABVC)

NCM – Real Time Price. Currency in USD

1.05

+0.03 (2.94%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

510K

152K

970K

Cost of goods sold

-505K

-202K

-682K

-310K

Gross Profit

-505K

308K

-530K

660K

Operating expenses (excl. COGS)

-7M

-5M

-6M

-16M

Operating Income

-7M

-5M

-7M

-15M

Non-operating income, total

-1M

-664K

-1M

-400K

Pretax income

-8M

-5M

-8M

-16M

Equity in earnings

Taxes

-24K

111K

-256K

-798K

Non-controlling/minority interest

468K

356K

493K

-111K

After tax other income/expense

Net income before discontinued operations

-8M

-5M

-8M

-16M

ABVC BioPharma, Inc. (ABVC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ABVC BioPharma, Inc. (ABVC)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

ABVC BioPharma, Inc. (ABVC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ABVC BioPharma, Inc. (ABVC)

Income Statement (Annual)

Income Statement (Annual)